
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Phosphatidylinositol (PI) is a phospholipid that serves as a precursor to crucial signaling molecules like PIP2 and inositol 1,4,5-trisphosphate (IP3). It supports cellular communication through the phosphoinositide signaling pathway, which regulates calcium release and protein kinase C activation.

Reported Benefits (Provisional)
Origin & History

Phosphatidylinositol (PI) is a phospholipid found in cell membranes, particularly in the brain and liver. It is extracted from soy lecithin through a series of purification processes.
Research Narrative (Provisional)
Preliminary studies, including in vitro and animal research, suggest PI's role in cellular signaling and liver health. Limited human trials are available.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains inositol, important for cellular communication. - Rich in essential fatty acids. - Provides phosphorous, vital for cellular processes.
Reported Mechanism (Provisional)
Phosphatidylinositol functions as a membrane phospholipid that gets phosphorylated to form PIP2 (phosphatidylinositol 4,5-bisphosphate) by phosphatidylinositol kinases. Upon stimulation, phospholipase C cleaves PIP2 into IP3 and diacylglycerol (DAG), triggering calcium release from intracellular stores and activating protein kinase C. This cascade regulates numerous cellular processes including neurotransmitter release, membrane transport, and gene expression.
Clinical Narrative (Provisional)
Research on phosphatidylinositol is primarily limited to cell culture and animal studies examining its role in cellular signaling pathways. Small human studies have suggested potential cognitive benefits when combined with other phospholipids, but isolated PI supplementation lacks robust clinical evidence. Most research focuses on PI's metabolites like inositol rather than PI itself. Current evidence is insufficient to establish definitive therapeutic dosages or clinical efficacy for supplemental phosphatidylinositol.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







